Barclays’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$374K Buy
35,390
+7,379
+26% +$78K ﹤0.01% 3188
2025
Q1
$420K Sell
28,011
-6,746
-19% -$101K ﹤0.01% 2936
2024
Q4
$571K Buy
34,757
+2,093
+6% +$34.4K ﹤0.01% 2977
2024
Q3
$806K Buy
32,664
+13,054
+67% +$322K ﹤0.01% 2748
2024
Q2
$497K Sell
19,610
-8,244
-30% -$209K ﹤0.01% 2543
2024
Q1
$708K Sell
27,854
-9,972
-26% -$253K ﹤0.01% 2627
2023
Q4
$858K Buy
37,826
+11,061
+41% +$251K ﹤0.01% 2706
2023
Q3
$499K Buy
26,765
+2,209
+9% +$41.2K ﹤0.01% 2563
2023
Q2
$637K Buy
24,556
+3,988
+19% +$103K ﹤0.01% 2446
2023
Q1
$591K Sell
20,568
-4,405
-18% -$127K ﹤0.01% 2528
2022
Q4
$738K Sell
24,973
-340
-1% -$10K ﹤0.01% 2345
2022
Q3
$602K Buy
25,313
+20,771
+457% +$494K ﹤0.01% 2473
2022
Q2
$101K Sell
4,542
-7,105
-61% -$158K ﹤0.01% 3454
2022
Q1
$293K Sell
11,647
-7,199
-38% -$181K ﹤0.01% 3103
2021
Q4
$676K Buy
18,846
+6,193
+49% +$222K ﹤0.01% 2390
2021
Q3
$538K Buy
12,653
+3,667
+41% +$156K ﹤0.01% 2574
2021
Q2
$389K Sell
8,986
-18,551
-67% -$803K ﹤0.01% 2597
2021
Q1
$1.12M Buy
27,537
+3,807
+16% +$155K ﹤0.01% 2232
2020
Q4
$1.07M Sell
23,730
-5,645
-19% -$255K ﹤0.01% 1934
2020
Q3
$1.04M Buy
29,375
+4,897
+20% +$173K ﹤0.01% 1900
2020
Q2
$924K Buy
24,478
+10,339
+73% +$390K ﹤0.01% 1975
2020
Q1
$409K Sell
14,139
-13,694
-49% -$396K ﹤0.01% 2214
2019
Q4
$1.44M Sell
27,833
-7,332
-21% -$380K ﹤0.01% 2072
2019
Q3
$1.93M Buy
35,165
+3,366
+11% +$185K ﹤0.01% 1789
2019
Q2
$1.29M Buy
31,799
+15,092
+90% +$613K ﹤0.01% 2155
2019
Q1
$506K Buy
16,707
+10,216
+157% +$309K ﹤0.01% 2607
2018
Q4
$219K Sell
6,491
-14,216
-69% -$480K ﹤0.01% 2686
2018
Q3
$872K Buy
20,707
+12,008
+138% +$506K ﹤0.01% 2334
2018
Q2
$279K Sell
8,699
-20,394
-70% -$654K ﹤0.01% 2574
2018
Q1
$1.45M Sell
29,093
-4,671
-14% -$232K ﹤0.01% 1560
2017
Q4
$1.82M Buy
33,764
+4,482
+15% +$242K ﹤0.01% 1304
2017
Q3
$1.7M Sell
29,282
-5,579
-16% -$324K ﹤0.01% 1312
2017
Q2
$1.72M Buy
34,861
+15,559
+81% +$768K ﹤0.01% 1289
2017
Q1
$839K Buy
19,302
+12,483
+183% +$543K ﹤0.01% 1661
2016
Q4
$333K Sell
6,819
-18,769
-73% -$917K ﹤0.01% 2038
2016
Q3
$1.22M Sell
25,588
-1,539
-6% -$73.6K ﹤0.01% 1312
2016
Q2
$1.46M Sell
27,127
-13,091
-33% -$702K ﹤0.01% 1256
2016
Q1
$1.77M Buy
40,218
+718
+2% +$31.6K ﹤0.01% 1137
2015
Q4
$1.5M Buy
39,500
+20,723
+110% +$787K ﹤0.01% 1182
2015
Q3
$582K Buy
18,777
+7,298
+64% +$226K ﹤0.01% 1665
2015
Q2
$378K Buy
11,479
+11,044
+2,539% +$364K ﹤0.01% 1862
2015
Q1
$18K Sell
435
-387
-47% -$16K ﹤0.01% 3147
2014
Q4
$33K Sell
822
-789
-49% -$31.7K ﹤0.01% 3209
2014
Q3
$58K Sell
1,611
-4,319
-73% -$155K ﹤0.01% 2912
2014
Q2
$272K Buy
5,930
+2,629
+80% +$121K ﹤0.01% 2247
2014
Q1
$135K Buy
3,301
+93
+3% +$3.8K ﹤0.01% 2597
2013
Q4
$122K Sell
3,208
-848
-21% -$32.2K ﹤0.01% 2920
2013
Q3
$93K Buy
4,056
+1,777
+78% +$40.7K ﹤0.01% 2974
2013
Q2
$38K Buy
+2,279
New +$38K ﹤0.01% 3449